# Named Patient Program for Mitomycin for Pyelocalyceal Solution

> **NCT05494411** · — · AVAILABLE · sponsor: **UroGen Pharma Ltd.**

## Conditions studied

- Urothelial Cancer of Renal Pelvis
- Urothelial Carcinoma of the Renal Pelvis and Ureter
- Urothelial Carcinoma Ureter
- Urothelial Carcinoma Ureter Recurrent
- Urothelial Carcinoma
- Urothelial Carcinoma Recurrent

## Interventions

- **DRUG:** Mitomycin for pyelocalyceal solution

## Key facts

- **NCT ID:** NCT05494411
- **Lead sponsor:** UroGen Pharma Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2025-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05494411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05494411, "Named Patient Program for Mitomycin for Pyelocalyceal Solution". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05494411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*